3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Rectal Neoplasms
5
Colorectal Neoplasms
4
Colonic Neoplasms
4
Urinary Bladder Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Pancreatic Neoplasms
2
Klatskin Tumor
2
Gallbladder Neoplasms
2
Cholangiocarcinoma
2
Tongue Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Salivary Gland Neoplasms
1
Pancreatic Intraductal Neoplasms
1
PRETEXT I Hepatoblastoma
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Lymphoid Interstitial Pneumonia
1
HIV Infections
1
Gastrointestinal Neoplasms
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
DNA Repair-Deficiency Disorders
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Clinical Stage I Gastric Cancer AJCC v8
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Bile Duct Neoplasms
1
Interventions
Doxorubicin
9
Specimen Handling
7
Sorafenib
7
Erlotinib Hydrochloride
7
Oxaliplatin
6
Magnetic Resonance Spectroscopy
6
Leucovorin
6
Fluorouracil
5
Thalidomide
4
Radiofrequency Ablation
4
Bevacizumab
4
tremelimumab
3
cediranib
3
cabozantinib
3
Trastuzumab
3
Pharmacogenomic Testing
3
Nivolumab
3
Neoadjuvant Therapy
3
Melphalan
3
MK 2206
3
Irinotecan
3
Fluorodeoxyglucose F18
3
Dasatinib
3
Cisplatin
3
Chemotherapy, Adjuvant
3
Bortezomib
3
Biopsy
3
AZD 6244
3
trametinib
2
sargramostim
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NIH
×
Carcinoma, Hepatocellular
×
dehydroftorafur
×
Clear all
NCT02042443
2017-09-12
S1310
National Cancer Institute (NCI)
Phase 2
Completed
53 enrolled
13 charts